Skip to content

Effect of Baduanjin on cardiopulmonary function in patients with stage 3-5 chronic kidney disease: a randomized controlled study

Effect of Baduanjin on cardiopulmonary function in patients with stage 3-5 chronic kidney disease: a randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006004
Enrollment
Unknown
Registered
2022-05-14
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

The control group:Regular treatments
The experimental group:Baduanjin movement

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Patients who met the diagnostic criteria for CKD and were CKD3-5 without dialysis. ? Patients aged 18-75 years. ? Patients with independent movement ability and able to complete baduanjin movement. ? Informed consent.

Exclusion criteria

Exclusion criteria: ? If the following conditions need emergency treatment, the patient shall be excluded: HGB 5.5mmol/L. ? Pregnant or lactating women. ? Complicated with active malignant tumor, decompensated liver cirrhosis, gastrointestinal bleeding, hematopoietic system serious primary diseases; Patients with serious heart and lung diseases, such as acute myocardial infarction, unstable angina pectoris, acute pulmonary embolism or pulmonary infarction; Severe hypertension (systolic blood pressure =200mmHg, diastolic blood pressure =120mmHg) and difficult to control blood pressure; Severe vasculitis of lower extremities, deep venous thrombosis of lower extremities; Patients with muscle, bone, joint and other motor system lesions who cannot or should not exercise. ? Patients with severe mental and cognitive disorders. ? Patients are participating in other researches.

Design outcomes

Primary

MeasureTime frame
peak oxygen uptake,PeakVO2;

Secondary

MeasureTime frame
Indicators of body function and nutritional status;Indicators of body function and nutritional status;Quality of Life;The quality of sleep;Indicators of body function and nutritional status;

Countries

China

Contacts

Public ContactXindong Qin

Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences

nealtcm@gzucm.edu.cn020-81887233-34330

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026